Clinical Trials in Philadelphia

Showing 5021-5040 of 20,904 trials

Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection

NCT03266627

Related donor Adenovirus (ADV) specific cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Cytokine Capture System will be administered intravenously in in children, adolescents and young adults with refractory ADV infection post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT), with primary immunodeficiencies (PID) or post solid organ transplant. Funding Source: FDA OOPD

AdenovirusPrimary Immune Deficiency Disorder

New York Medical College20 participantsStarted Nov 2018

Los Angeles, California, United States • San Francisco, California, United States • Aurora, Colorado, United States +7 more locations

RECRUITINGPhase 2< 1 mile

Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)

NCT03266640

CMV cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Cytokine Capture System will be administered in children, adolescents and young adults (CAYA) with refractory cytomegalovirus (CMV) infection post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT), with primary immunodeficiencies (PID) or post solid organ transplant. Funding Source: FDA OOPD

Cytomegalovirus InfectionsPrimary Immune Deficiency Disorder

New York Medical College20 participantsStarted Nov 2018

Los Angeles, California, United States • San Francisco, California, United States • Indianapolis, Indiana, United States +6 more locations

Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection

Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)

Find Trials by Condition in Philadelphia

EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection

tACS to Enhance Language Abilities

Improving Sleep in the Neurology In-Patient Population

Conventional Endoscopic Techniques Versus EndoRotor® System for Necrosectomy of Walled of Necrosis

DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)

RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder

The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System

A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer

Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma

HPV Vaccine Confident Families

Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and Effectiveness of Oli for Identification of Patients, During the Intrapartum Period, Who Are at Higher Risk of Developing Abnormal Postpartum Uterine Bleeding, Including Postpartum Haemorrhage

A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease

Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease

A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.

EMPOWER AUD Pivotal Trial

Prevalence of Multidrug Resistant Micro-organism Carriage in Patients Undergoing an ERCP in Four Different Countries

A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC)